Identification of Immune-Related Genes in Patients with Acute Myocardial Infarction Using Machine Learning Methods

References

• Harjola VP, Lassus J, Sionis A, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17(5):501–509. doi:10.1002/ejhf.260
   PubMed Web of Science ®Google Scholar
• McManus DD, Piacentine SM, Lessard D, et al. Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction. Am J Cardiol. 2011;108(4):477–482. doi:10.1016/j.amjcard.2011.03.074
   PubMed Web of Science ®Google Scholar
• Gulati R, Behfar A, Narula J, et al. Acute myocardial infarction in young individuals. Mayo Clin Proc. 2020;95(1):136–156. doi:10.1016/j.mayocp.2019.05.001
   PubMed Web of Science ®Google Scholar
• Roth GA, Huffman MD, Moran AE, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132(17):1667–1678. doi:10.1161/CIRCULATIONAHA.114.008720
   PubMed Web of Science ®Google Scholar
• Abed MA, Khalil AA, Moser DK. The contribution of symptom incongruence to prehospital delay for acute myocardial infarction symptoms among Jordanian patients. Res Nurs Health. 2015;38(3):213–221. doi:10.1002/nur.21658
   PubMed Web of Science ®Google Scholar
• Xie Y, Wang Y, Zhao L, Wang F, Fang J. Identification of potential biomarkers and immune cell infiltration in acute myocardial infarction (AMI) using bioinformatics strategy. Bioengineered. 2021;12(1):2890–2905. doi:10.1080/21655979.2021.1937906
   PubMed Web of Science ®Google Scholar
• Kologrivova I, Shtatolkina M, Suslova T, Ryabov V. Cells of the immune system in cardiac remodeling: main players in resolution of inflammation and repair after myocardial infarction. Front Immunol. 2021;12:664457. doi:10.3389/fimmu.2021.664457
   PubMed Web of Science ®Google Scholar
• Zhao E, Xie H, Zhang Y. Predicting diagnostic gene biomarkers associated with immune infiltration in patients with acute myocardial infarction. Front Cardiovasc Med. 2020;7:586871. doi:10.3389/fcvm.2020.586871
   PubMed Web of Science ®Google Scholar
• Ong SB, Hernández-Reséndiz S, Crespo-Avilan GE, et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018;186:73–87. doi:10.1016/j.pharmthera.2018.01.001
   PubMed Web of Science ®Google Scholar
• Ministrini S, Carbone F, Montecucco F. Updating concepts on atherosclerotic inflammation: from pathophysiology to treatment. Eur J Clin Invest. 2021;51(5):e13467. doi:10.1111/eci.13467
   PubMed Web of Science ®Google Scholar
• Orn S, Manhenke C, Squire IB, Ng L, Anand I, Dickstein K. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function. J Card Fail. 2007;13(10):843–849. doi:10.1016/j.cardfail.2007.07.006
   PubMed Web of Science ®Google Scholar
• Oba T, Yasukawa H, Hoshijima M, et al. Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol. 2012;59(9):838–852. doi:10.1016/j.jacc.2011.10.887
   PubMed Web of Science ®Google Scholar
• Xu JY, Xiong YY, Lu XT, Yang YJ. Regulation of type 2 immunity in myocardial infarction. Front Immunol. 2019;10:62. doi:10.3389/fimmu.2019.00062
   PubMed Web of Science ®Google Scholar
• Liu W, Shen J, Li Y, et al. Pyroptosis inhibition improves the symptom of acute myocardial infarction. Cell Death Dis. 2021;12(10):852. doi:10.1038/s41419-021-04143-3
   PubMed Web of Science ®Google Scholar
• Xiong YY, Gong ZT, Tang RJ, Yang YJ. The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction. Theranostics. 2021;11(3):1046–1058. doi:10.7150/thno.53326
   PubMed Web of Science ®Google Scholar
• Jukes E. Encyclopedia of machine learning and data mining (2nd edition). Reference Rev. 2018;32(7/8):3–4. doi:10.1108/RR-05-2018-0084
   Google Scholar
• Chen C, Grennan K, Badner J, et al. Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods. PLoS One. 2011;6(2):e17238. doi:10.1371/journal.pone.0017238
   PubMed Web of Science ®Google Scholar
• Li W. Volcano plots in analyzing differential expressions with mRNA microarrays. J Bioinform Comput Biol. 2012;10(6):1231003. doi:10.1142/S0219720012310038
   PubMed Web of Science ®Google Scholar
• Walter W, Sánchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31(17):2912–2914. doi:10.1093/bioinformatics/btv300
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. doi:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• Kuhn M. Caret: classification and regression training. 2013.
   Google Scholar
• Breiman, L. Random Forests. Machine Learning 45, 5–32 (2001). 10.1023/A:1010933404324
   Google Scholar
• Dimitriadou E, Hornik K, Leisch F, Meyer D, Weingessel A. e1071: misc functions of the department of statistics (e1071). 2011.
   Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22. doi:10.18637/jss.v033.i01
   PubMed Web of Science ®Google Scholar
• Sorokin AA, Dmitriev VN, Toan TQ, Reznikov PS. neuralnet: training of neural networks. RJ. 2014;2:30.
   Google Scholar
• Palla TG, Tayeb S. Intelligent Mirai malware detection for IoT nodes %. J Electron. 2021;10(11):1241. doi:10.3390/electronics10111241
   Web of Science ®Google Scholar
• Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. doi:10.1371/journal.pbio.3000410
   PubMed Web of Science ®Google Scholar
• Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35(42):2950–2959. doi:10.1093/eurheartj/ehu299
   PubMed Web of Science ®Google Scholar
• Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155–2165. doi:10.1056/NEJMoa0908610
   PubMed Web of Science ®Google Scholar
• Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389(10065):197–210. doi:10.1016/S0140-6736(16)30677-8
   PubMed Web of Science ®Google Scholar
• Visan I. Myocardial infarct inflammation. Nat Immunol. 2018;19(2):99.
   Web of Science ®Google Scholar
• Nahrendorf M. Myeloid cell contributions to cardiovascular health and disease. Nat Med. 2018;24(6):711–720. doi:10.1038/s41591-018-0064-0
   PubMed Web of Science ®Google Scholar
• Swirski FK, Nahrendorf M. Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat Rev Immunol. 2018;18(12):733–744. doi:10.1038/s41577-018-0065-8
   PubMed Web of Science ®Google Scholar
• Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357(11):1121–1135. doi:10.1056/NEJMra071667
   PubMed Web of Science ®Google Scholar
• Morton AC, Rothman AM, Greenwood JP, et al. The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study. Eur Heart J. 2015;36(6):377–384. doi:10.1093/eurheartj/ehu272
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–1131. doi:10.1056/NEJMoa1707914
   PubMed Web of Science ®Google Scholar
• Marinković G, Grauen Larsen H, Yndigegn T, et al. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction. Eur Heart J. 2019;40(32):2713–2723. doi:10.1093/eurheartj/ehz461
   PubMed Web of Science ®Google Scholar
• Scarabelli TM, Stephanou A, Pasini E, et al. Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ Res. 2002;90(6):745–748. doi:10.1161/01.RES.0000015224.07870.9A
   PubMed Web of Science ®Google Scholar
• Baker BJ, Akhtar LN, Benveniste EN. SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol. 2009;30(8):392–400. doi:10.1016/j.it.2009.07.001
   PubMed Web of Science ®Google Scholar
• Negoro S, Kunisada K, Fujio Y, et al. Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation. 2001;104(9):979–981. doi:10.1161/hc3401.095947
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 2007;7(6):454–465. doi:10.1038/nri2093
   PubMed Web of Science ®Google Scholar
• Chen Z, Laurence A, Kanno Y, et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci U S A. 2006;103(21):8137–8142. doi:10.1073/pnas.0600666103
   PubMed Web of Science ®Google Scholar
• Barin JG, Baldeviano GC, Talor MV, et al. Macrophages participate in IL-17-mediated inflammation. Eur J Immunol. 2012;42(3):726–736. doi:10.1002/eji.201141737
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhao Q, Sun H, et al. Scolopendra subspinipes mutilans L. Koch ameliorates rheumatic heart disease by affecting relative percentages of CD4(+)CD25(+)FoxP3 Treg and CD4(+)IL17 T Cells. eCAM. 2019;2019:4674190. doi:10.1155/2019/4674190
   Web of Science ®Google Scholar
• López E, Blázquez R, Marinaro F, et al. The intrapericardial delivery of extracellular vesicles from cardiosphere-derived cells stimulates M2 polarization during the acute phase of porcine myocardial infarction. Stem Cell Rev Rep. 2020;16(3):612–625. doi:10.1007/s12015-019-09926-y
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11(5):255–265. doi:10.1038/nrcardio.2014.28
   PubMed Web of Science ®Google Scholar
• Yan W, Song Y, Zhou L, et al. Immune cell repertoire and their mediators in patients with acute myocardial infarction or stable angina pectoris. Int J Med Sci. 2017;14(2):181–190. doi:10.7150/ijms.17119
   PubMed Web of Science ®Google Scholar
• Varda-Bloom N, Leor J, Ohad DG. Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro %. J Mol Cell Cardiol. 2000;32(12):2141–2149. doi:10.1006/jmcc.2000.1261
   PubMed Web of Science ®Google Scholar
• Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circulation Research. 2016;119(1):91–112. doi:10.1161/CIRCRESAHA.116.303577
   PubMed Web of Science ®Google Scholar
• Carbone F, Nencioni A, Mach F, Vuilleumier N, Montecucco F. Pathophysiological role of neutrophils in acute myocardial infarction. Thromb Haemost. 2013;110(3):501–514. doi:10.1160/TH13-03-0211
   PubMed Web of Science ®Google Scholar
• Ma Y, Yabluchanskiy A, Iyer RP, et al. Temporal neutrophil polarization following myocardial infarction. Cardiovasc Res. 2016;110(1):51–61. doi:10.1093/cvr/cvw024
   PubMed Web of Science ®Google Scholar
• Braunersreuther V, Montecucco F, Pelli G, et al. Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice. Thromb Haemost. 2013;110(4):807–825. doi:10.1160/TH13-04-0297
   PubMed Web of Science ®Google Scholar
• Carbone F, Crowe LA, Roth A, et al. Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury. J Mol Cell Cardiol. 2016;94:82–94. doi:10.1016/j.yjmcc.2016.03.013
   PubMed Web of Science ®Google Scholar
• Shishido T, Nozaki N, Takahashi H, et al. Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury. Biochem Biophys Res Commun. 2006;345(4):1446–1453. doi:10.1016/j.bbrc.2006.05.056
   PubMed Web of Science ®Google Scholar
• Gavins FN. Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury? Trends Pharmacol Sci. 2010;31(6):266–276. doi:10.1016/j.tips.2010.04.001
   PubMed Web of Science ®Google Scholar
• Qin C, Buxton KD, Pepe S, et al. Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26). Br J Pharmacol. 2013;168(1):238–252. doi:10.1111/j.1476-5381.2012.02176.x
   PubMed Web of Science ®Google Scholar
• Ren N, Wang M. microRNA-212-induced protection of the heart against myocardial infarction occurs via the interplay between AQP9 and PI3K/Akt signaling pathway. Exp Cell Res. 2018;370(2):531–541. doi:10.1016/j.yexcr.2018.07.018
   PubMed Web of Science ®Google Scholar
• Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J. 1994;8(15):1314–1325. doi:10.1096/fasebj.8.15.8001745
   PubMed Web of Science ®Google Scholar
• Peters VA, Joesting JJ, Freund GG. IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Brain Behav Immun. 2013;32:1–8. doi:10.1016/j.bbi.2012.11.006
   PubMed Web of Science ®Google Scholar